EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Annual Banned‐Substance Review 17th Edition—Analytical Approaches in Human Sports Drug Testing 2023/2024

Mario Thevis iD, Tiia Kuuranne, Hans Geyer

Drug Testing and Analysis · 2025

DOI: 10.1002/dta.3835 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Testing and Analysis, 2025. Verfasst von Mario Thevis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Preventive Doping Research, Institute of Biochemistry, German Sport University Cologne, Cologne, Germany. Hauptthemen laut MEDLINE: Doping in Sports, Substance Abuse Detection, Performance-Enhancing Substances, Anabolic Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Manfred Donike Institut für Dopinganalytik, Bundesministerium des Innern, für Bau und Heimat.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 17th edition of the annual banned‐substance review on analytical approaches in human sports drug testing is dedicated to literature published between October 2023 and September 2024. As in previous years, focus is put particularly on new or enhanced analytical options in human doping controls as well as investigations into the metabolism and elimination of compounds of interest, which represent central (while not exclusive) cornerstones of the global anti‐doping mission. New information published within the past 12 months on established doping agents as well as new potentially relevant substances are reviewed and discussed in the context of the World Anti‐Doping Agency's 2024 Prohibited List. Thereby, analytical challenges, especially with regard to the continuously growing number of target compounds and potentially relevant drug classes as well as the exigency (and consequences) of utmost analytical retrospectivity, are thematized and contextualized. Investigations especially into anabolic agents, peptide hormones, and strategies for the detection of gene doping were identified as core areas of anti‐doping research in the reviewed period.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Doping in SportsSubstance Abuse DetectionPerformance-Enhancing SubstancesAnabolic AgentsHumans

Stichwörter der Autor:innen

doping |exposure |gene doping |semaglutide |sport

Substanzen

Performance-Enhancing SubstancesAnabolic Agents

Autor:innen und Institutionen

  • Center for Preventive Doping Research, Institute of Biochemistry, German Sport University Cologne, Cologne, Germany.
  • European Monitoring Center for Emerging Doping Agents, Cologne, Germany.
  • Swiss Laboratory for Doping Analyse, University Center of Legal Medicine, Genève and Lausanne, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Epalinges, Switzerland.

ORCID-Profile: Mario Thevis

Förderung

  • Manfred Donike Institut für Dopinganalytik
  • Bundesministerium des Innern, für Bau und Heimat

Zitieren

APA

Thevis, M., Kuuranne, T., & Geyer, H. (2025). Annual Banned‐Substance Review 17th Edition—Analytical Approaches in Human Sports Drug Testing 2023/2024. Drug Testing and Analysis. https://doi.org/10.1002/dta.3835

Vancouver

Thevis M, Kuuranne T, Geyer H. Annual Banned‐Substance Review 17th Edition—Analytical Approaches in Human Sports Drug Testing 2023/2024. Drug Testing and Analysis. 2025. doi:10.1002/dta.3835

BibTeX
@article{Thevis2025,
  author = {Thevis, Mario and Kuuranne, Tiia and Geyer, Hans},
  title = {Annual Banned‐Substance Review 17th Edition—Analytical Approaches in Human Sports Drug Testing 2023/2024},
  journal = {Drug Testing and Analysis},
  year = {2025},
  doi = {10.1002/dta.3835}
}
Kostenlos starten →